Jefferies Raises Price Target on Sucampo Pharma (SCMP) Following 3Q Report
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Alphabet added to Dow Jones Industrial Average, Verizon dropped
- Chip stocks plunge, but bargain-hunters limit scale of tech rout
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
Sucampo Reports Third Quarter 2016 Financial Results
November 9, 2016 6:30 AM ESTResults Driven by 73% Growth in Revenue
GAAP EPS Growth of 12%; Adjusted EPS Growth of 58%
Company Raises 2016 Guidance and Provides Preliminary 2017 Guidance
Announces Settlement with Dr. Reddys Laboratories for AMITIZA
Reports Phase Three Results for AMITIZA in Pediatric Population
Company to Host Conference Call Today at 8:30 a.m. EST
ROCKVILLE, Md., Nov. 09, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals,... More
